318 related articles for article (PubMed ID: 19069453)
21. Plasma glucagon decreases during night-time sleep in Type 1 diabetic patients and healthy control subjects.
Jauch-Chara K; Hallschmid M; Schmid SM; Oltmanns KM; Peters A; Born J; Schultes B
Diabet Med; 2007 Jun; 24(6):684-7. PubMed ID: 17381498
[TBL] [Abstract][Full Text] [Related]
22. [Altered circadian rhythm of platelet aggregation in patients on longterm hemodialysis].
Rydzewski A; Małyszko J; Borawski J; Pawlak D; Adamcewicz K; Buczko W; Myśliwiec M
Przegl Lek; 1997; 54(3):167-70. PubMed ID: 9297192
[TBL] [Abstract][Full Text] [Related]
23. Circadian variations in platelet aggregability in non insulin dependent diabetes patients (NIDDM).
Spanò GM; La Mancusa R; Pettirossi G; Pulcinelli FM; Gazzaninga PP; Cordova C
Clin Ter; 1993 Jan; 142(1):19-22. PubMed ID: 8472505
[TBL] [Abstract][Full Text] [Related]
24. Circadian variation within hemostasis: an underrecognized link between biology and disease?
Montagnana M; Salvagno GL; Lippi G
Semin Thromb Hemost; 2009 Feb; 35(1):23-33. PubMed ID: 19308890
[TBL] [Abstract][Full Text] [Related]
25. [Diabetes mellitus and fibrinolysis (experience with an in vitro clot lysis test)].
Udvardy M; Pósán E
Orv Hetil; 1994 Sep; 135(37):2025-7. PubMed ID: 7936609
[TBL] [Abstract][Full Text] [Related]
26. Coagulation in diabetic and non-diabetic claudicants.
Gosk-Bierska I; Adamiec R; Alexewicz P; Wysokinski WE
Int Angiol; 2002 Jun; 21(2):128-33. PubMed ID: 12110772
[TBL] [Abstract][Full Text] [Related]
27. Effects of conventional or extended-cycle regimen of an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on various hemostasis parameters.
Wiegratz I; Stahlberg S; Manthey T; Sänger N; Mittmann K; Lange E; Mellinger U; Kuhl H
Contraception; 2008 Nov; 78(5):384-91. PubMed ID: 18929735
[TBL] [Abstract][Full Text] [Related]
28. A randomized, controlled study on the influence of acetaminophen, diclofenac, or naproxen on aspirin-induced inhibition of platelet aggregation.
Galliard-Grigioni KS; Reinhart WH
Eur J Pharmacol; 2009 May; 609(1-3):96-9. PubMed ID: 19272375
[TBL] [Abstract][Full Text] [Related]
29. [Do all the patients with adult-onset diabetes mellitus need acetylsalicylic acid?].
Lassila R
Duodecim; 1999; 115(10):1174-7. PubMed ID: 11877857
[No Abstract] [Full Text] [Related]
30. [Hemostatic studies in decompensated diabetes mellitus].
Petrunova N; Genova V
Vutr Boles; 1988; 27(5):43-6. PubMed ID: 3213038
[TBL] [Abstract][Full Text] [Related]
31. [Possibility of regulating platelet aggregation ability with the S2-receptor blocker, naftidrofuril, in patients with insulin-dependent diabetes mellitus].
Balashova TS; Kubatiev AA
Vopr Med Khim; 1996; 42(4):337-43. PubMed ID: 9254523
[TBL] [Abstract][Full Text] [Related]
32. [Biological rhythm and thromboembolic disease. Physiological, epidemiological and pharmacological aspects].
Decousus H; Ollagnier M; Jaubert J; Perpoint B; Hocquart J; Queneau P
Pathol Biol (Paris); 1987 Jun; 35(6):985-90. PubMed ID: 3306580
[TBL] [Abstract][Full Text] [Related]
33. Alterations of the characteristics of the circadian rest-activity rhythm of cancer in-patients.
Pati AK; Parganiha A; Kar A; Soni R; Roy S; Choudhary V
Chronobiol Int; 2007; 24(6):1179-97. PubMed ID: 18075806
[TBL] [Abstract][Full Text] [Related]
34. Aspirin response and failure in diabetic patients with cardiovascular disease.
Yan Y; Phillips DR
Curr Opin Pharmacol; 2005 Apr; 5(2):190-7. PubMed ID: 15780830
[TBL] [Abstract][Full Text] [Related]
35. [State of the microcirculatory component of hemostasis and microhemodynamics in patients with diabetic angiopathies].
Petrova TR; Pavlishchuk SA; Vil'chinskaia MN
Ter Arkh; 1984; 56(8):129-32. PubMed ID: 6495194
[TBL] [Abstract][Full Text] [Related]
36. A low dose of aspirin (75 mg/day) lowers thrombin generation to a similar extent as a high dose of aspirin (300 mg/day).
Undas A; Undas R; Musiał J; Szczeklik A
Blood Coagul Fibrinolysis; 2000 Apr; 11(3):231-4. PubMed ID: 10870801
[TBL] [Abstract][Full Text] [Related]
37. Circadian variations in coagulation and fibrinolytic factors among four different strains of mice.
Ohkura N; Oishi K; Sakata T; Kadota K; Kasamatsu M; Fukushima N; Kurata A; Tamai Y; Shirai H; Atsumi G; Ishida N; Matsuda J; Horie S
Chronobiol Int; 2007; 24(4):651-69. PubMed ID: 17701678
[TBL] [Abstract][Full Text] [Related]
38. [Diabetes mellitus and changes in hemostasis: study of the fibrinolytic response of insulin-dependent patients without vascular disease].
García Pérez AA; Marco Vera P; Mompel Sanjuan A; Abad Gosalbez A
Rev Clin Esp; 1989 Feb; 184(3):128-30. PubMed ID: 2717790
[TBL] [Abstract][Full Text] [Related]
39. Circadian variations in natural coagulation inhibitors protein C, protein S and antithrombin in healthy men: a possible association with interleukin-6.
Undar L; Ertuğrul C; Altunbaş H; Akça S
Thromb Haemost; 1999 Apr; 81(4):571-5. PubMed ID: 10235441
[TBL] [Abstract][Full Text] [Related]
40. Circadian variations in blood coagulation parameters, alpha-antitrypsin antigen and platelet aggregation and retention in clinically healthy subjects.
Haus E; Cusulos M; Sackett-Lundeen L; Swoyer J
Chronobiol Int; 1990; 7(3):203-16. PubMed ID: 2125246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
